SS-31 and People Panicing
Good morning, all of you peptide lovers, and happy Friyay!!!
So, for a little information of what is happening with the SS-31 now that it is getting final approvals from the FDA to be prescribed for Barth Syndrome. Stealth BioTherapeutics received FDA accelerated approval for SS-31 on 9/19/2025. Accelerated means they can start marketing it immediately. It will be branded under the name Forzinity. With this, they started sending American companies cease and desist letters to stop selling SS-31 under the name of SS-31.
If you have been around for a bit, you already know this occurred with Sema and Tirz from Ely Lilly and Novo Nordisk. That is why you will find these being sold, usually, under GLP-1 and GLP-2, plus a lot seen Reta getting close to FDA approvals so they also moved Reta to GLP-3. This will be the same thing that will happen with SS-31, in fact it has already started by smart companies getting ahead of the game before receiving their cease and desist letter.
SS-31 Getting Renamed to MTP-31 at Peptira.
PLEASE DO STOP THE FREAK OUT AND BUYING UP ALL OF THE SS-31 BECAUSE IT IS GOING TO DRIVE THE PRICE THROUGH THE ROOF FOR NO REASON.
And be ready, because you will see this more with other peptides in the near future. Here is the deal, China don't give a shit about the FDA not allowing American companies to sell it under SS-31. They will continue to produce it, and the American companies will just put different labels on them.
Take a deep breath, this is part of the game, and we will continue to be provided. Have an amazing, relaxing weekend!! 🫶💉🙈🙊🙉
8
46 comments
Pump Robbennolt
5
SS-31 and People Panicing
powered by
Peptides4Power
skool.com/peptides4power-4793
Peptide Education & Information + Trusted Vendors
Build your own community
Bring people together around your passion and get paid.
Powered by